Printer Friendly

Impact of Existing and Emerging Parenteral Drug Market Trends 2018 to 2028.

Fact.MR has announced the addition of the "Parenteral Drug Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

[USPRwire, Mon Jul 15 2019] Parenteral drugs are called the dosage forms that are intended for administration of medicine as injection or infusion. Parenteral form refers to administration of medications skipping the digestive system, rather injected or infused via intravenous or intramuscular mode of delivery. There are four most common delivery routes for parenteral drug administration including intravenous (IV) route, intraosseous infusion, subcutaneous route and intramuscular route. In Intravenous route of drug delivery, medicines or medicinal fluids are directly injected into patient's vein. However, subcutaneous parenteral drug is given under the skin and intramuscular parenteral drug is injected into muscle. The intravenous (IV) administration route for parenteral drug delivery is highly preferred over other delivery routes. Though solid dosage medicinal products are still prevailing in the market, parenteral drugs despite being a small molecule or a biologic-based drug is expected to increase their revenue share in the overall drug market. The increasing approval for new parenteral drug across the globe is projected to propel parenteral drug market revenue growth over the forecast years. For instance, in 2016, 22 New Molecular Entities (NMEs) were approved by the US Food and Drug Administration's Center for Drug Evaluation and Research. 13, or say 59 percent of these 22 NMEs approved were registered to be parenteral drugs. The increase in product launch activities for parenteral drugs by leading manufacturers such as Eli Lilly and Company, Biogen Inc., Merck and others. With the increasing rise in development of biologic-based drugs, the number of parenteral drugs that are under development or are getting FDA approval is anticipated to increase, thereby being one of the most prominent factor fueling the growth of parenteral drug market. However, high costs associated with the parenteral drug is restraining the revenue growth in parenteral drug market. [c]ADownload Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3189 The parenteral drug market is categorized based on drug class, route of administration and distribution channel. Based on drug class, the parenteral drug are classified into six major drug classes. Out of the six major drug class, antibiotics are the most preferred parenteral drug type. The global parenteral drug market is segmented on basis of product type, material type, application type, end user and geographic region: Segmentation by Product Type Antibiotics Antineoplastic drug Anti-diabetic Drugs Analgesics Anti-inflammatory Drugs Anesthetics Others Segmentation by Route of Administration Intravenous (IV) Subcutaneous (subQ) Intramuscular (IM) Intradermal Segmentation by Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Drug Stores On the basis of product type, antibiotics parenteral drug segment is anticipated to expand its growth at a highest CAGR over the forecast years on the account of more demand for antibiotics from end use segments. However, the analgesics and anesthetics parenteral drug segment cumulatively holds the highest revenue share in parenteral drug market. Also, anti-inflammatory parenteral drug generates more revenue when compared to anti-diabetic parenteral drug. However, an upsurge in demand for Anti-diabetic parenteral drug is expected to exist in global parenteral drug market over the forecast period. Also, based on route of administration, parenteral drug are majorly injected via intravenous route. Hospital pharmacies followed by retail pharmacies is expected to register highest revenue growth rate during the forecast period. Download Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=3189 North America and Europe cumulatively are expected to register highest market revenue share in global parenteral drug market due to the increased patient pool in the regions along with presence of top manufacturing companies across the region. The launch of new parental drug after FDA approval in the U.S. market enables North America to capture highest revenue share in parenteral drug market. Asian countries due to strong footprint for pharmaceutical companies entirely focused on production of parenteral drug allows Asia Pacific to grow at a significant CAGR over the forecast period. Some of the major key manufacturers involved in global parenteral drug market are Eli Lilly and Company, Biogen Inc., Merck & Co., Sanofi, Novo Nordisk, AbbVie, Intercept Pharmaceuticals, Jazz Pharmaceuticals, Teva Pharmaceuticals and others. The report covers exhaustive analysis on: Parenteral Drug Market Segments Parenteral Drug Market Dynamics Historical Actual Market Size, 2012 - 2016 Parenteral Drug Market Size & Forecast 2016 to 2024 Parenteral Drug Market Current Trends/Issues/Challenges Competition & Companies involved Parenteral Drug Market Drivers and Restraints Regional analysis includes: North America Latin America Europe Asia Pacific Excluding China China Middle East & Africa Report Highlights: Shifting Industry dynamics In-depth market segmentation Historical, current and projected industry size Recent industry trends Key Competition landscape Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth A neutral perspective towards market performance Download Report Analysis@ https://www.factmr.com/report/3189/parenteral-drug-market About US Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports. Contact Us Rohit Bhisey Fact.MR 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Email: sales@factmr.com Web: https://www.factmr.com/ Blog: https://factmrblog.com/

Copyright [c] 2019 USPRwire Provided by SyndiGate Media Inc. ( Syndigate.info ).
COPYRIGHT 2019 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:USPRwire
Date:Jul 15, 2019
Words:909
Previous Article:Spine Surgery Robots Market Size, Share, Trends and Future Growth Predictions and Forecast 2018 -- 20.
Next Article:Discrete Diodes Market Poised for Steady Growth in the Future.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters